RYAM stock steadies after $1.2 billion sales in 2025

Rayonier Advanced Materials Inc. (US75522E1082) is supported by a 2025 revenue base of $1.2 billion and $122 million in adjusted EBITDA, according to its latest annual filing. The company also generated $44 million in free cash flow in 2025, giving RYAM stock a clear earnings-and-cash backdrop even without a fresh market catalyst.

2025 cash flow matters

For investors tracking the balance sheet, the same filing shows net debt of about $1.0 billion at year-end 2025, against a business that still produced positive free cash flow. That combination matters because it frames how much room Rayonier Advanced Materials has for deleveraging and capital allocation in 2026.

Adjusted EBITDA of $122 million in 2025 also sets a useful reference point for comparing future quarters. If the company can hold that operating level while expanding cash generation, the equity case changes faster than the top line alone suggests.

Revenue and margin base

The 2025 revenue figure of $1.2 billion is not the only number that counts, but it is the cleanest starting point for a stock that trades more on operational execution than on story stock narratives. The key comparison is that the company still turned that sales base into $44 million of free cash flow in the same year.

That conversion rate gives context to the 2025 margin structure: adjusted EBITDA of $122 million on $1.2 billion of sales implies an operating margin profile that still leaves little room for volatility. In practical terms, every quarter of price discipline or cost control can matter more than broad industry demand swings.

Balance sheet pressure

Net debt of $1.0 billion at 31 December 2025 remains the main financial constraint in the latest report. Against $122 million of adjusted EBITDA, that debt load is large enough to keep leverage in focus for 2026 reporting.

The comparison also helps explain why cash flow is more important than accounting profit for RYAM stock. A year with $44 million in free cash flow gives the market a concrete yardstick for what progress looks like in the next filing cycle.

Specialty products drive the mix

Rayonier Advanced Materials remains tied to specialty cellulose and high-purity materials, which are the product lines most likely to influence margin stability. Those businesses matter because the company’s 2025 adjusted EBITDA of $122 million had to come from a relatively concentrated industrial mix.

The market usually values that mix through cash conversion rather than simple volume growth. In 2025, the company delivered $44 million of free cash flow while carrying $1.0 billion of net debt, which makes product-level efficiency more relevant than raw revenue growth alone.

Latest stock context

RYAM stock trades on the New York Stock Exchange under the symbol NYSE: RYAM. The latest report gives the equity its strongest visible anchors right now: $1.2 billion in 2025 revenue, $122 million in adjusted EBITDA, $44 million in free cash flow, and $1.0 billion in net debt as of 31 December 2025.

Those figures define the current setup more clearly than any short-term noise. For a cyclical industrial name, the next reported change in cash generation will matter more than a simple rerating narrative.